{"id":"https://openalex.org/A5117935488","orcid":"https://orcid.org/0009-0008-1130-7709","observed_orcids":["https://orcid.org/0009-0008-1130-7709"],"display_name":"\u041a\u0443\u043b\u0438\u0435\u0432\u0430 \u042d\u043b\u044c\u0432\u0438\u043d\u0430 \u0420\u0443\u0441\u0442\u0430\u043c\u043e\u0432\u043d\u0430","raw_author_names":["E. R. Kulieva","Elvina R Kulieva","Elvina R. Kulieva","Elvina R. Kuliyeva","\u041a\u0443\u043b\u0438\u0435\u0432\u0430 \u042d. \u0420.","\u041a\u0443\u043b\u0438\u0435\u0432\u0430 \u042d\u043b\u044c\u0432\u0438\u043d\u0430 \u0420\u0443\u0441\u0442\u0430\u043c\u043e\u0432\u043d\u0430"],"full_name":"\u041a\u0443\u043b\u0438\u0435\u0432\u0430 \u042d\u043b\u044c\u0432\u0438\u043d\u0430 \u0420\u0443\u0441\u0442\u0430\u043c\u043e\u0432\u043d\u0430","works_count":8,"cited_by_count":1,"summary_stats":{"2yr_mean_citedness":0.0,"h_index":1,"i10_index":0},"ids":{"openalex":"https://openalex.org/A5117935488","orcid":"https://orcid.org/0009-0008-1130-7709","observed_orcids":["https://orcid.org/0009-0008-1130-7709"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4210164656","ror":"https://ror.org/05erbjx97","display_name":"V.I. Vernadsky Crimean Federal University","country_code":"UA","type":"education","lineage":["https://openalex.org/I4210164656"]},"years":[2025]}],"last_known_institutions":[{"id":"https://openalex.org/I4210164656","ror":"https://ror.org/05erbjx97","display_name":"V.I. Vernadsky Crimean Federal University","country_code":"UA","type":"education","lineage":["https://openalex.org/I4210164656"]}],"topics":[{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","count":3,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","count":3,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10041","display_name":"COVID-19 Clinical Research Studies","count":2,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11368","display_name":"Long-Term Effects of COVID-19","count":2,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","count":2,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T11368","display_name":"Long-Term Effects of COVID-19","value":1.63e-05,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12539","display_name":"Pharmacology and Obesity Treatment","value":1.33e-05,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T14078","display_name":"Multiple and Secondary Primary Cancers","value":1.22e-05,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11943","display_name":"Pharmacovigilance and Adverse Drug Reactions","value":7.9e-06,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","value":6.7e-06,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"116834253","wikidata":"https://www.wikidata.org/wiki/Q2039217","display_name":"Identification (biology)","score":0.19499999284744263},{"id":"18762648","wikidata":"https://www.wikidata.org/wiki/Q42213","display_name":"Work (physics)","score":0.18389999866485596},{"id":"2779343474","wikidata":"https://www.wikidata.org/wiki/Q3109175","display_name":"Context (archaeology)","score":0.16850000619888306},{"id":"177264268","wikidata":"https://www.wikidata.org/wiki/Q1514741","display_name":"Set (abstract data type)","score":0.16580000519752502},{"id":"2776608160","wikidata":"https://www.wikidata.org/wiki/Q4785462","display_name":"Natural (archaeology)","score":0.16120000183582306}],"counts_by_year":[{"year":2024,"works_count":1,"oa_works_count":0,"cited_by_count":1},{"year":2025,"works_count":5,"oa_works_count":3,"cited_by_count":0}],"display_name_alternatives":["E. R. Kulieva","Elvina R Kulieva","Elvina R. Kulieva","Elvina R. Kuliyeva","\u041a\u0443\u043b\u0438\u0435\u0432\u0430 \u042d. \u0420.","\u041a\u0443\u043b\u0438\u0435\u0432\u0430 \u042d\u043b\u044c\u0432\u0438\u043d\u0430 \u0420\u0443\u0441\u0442\u0430\u043c\u043e\u0432\u043d\u0430"],"block_key":"e kulieva","works_api_url":"https://api.openalex.org/works?filter=author.id:A5117935488","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5117935488","updated_date":"2026-11-17T13:41:00","created_date":"2025-10-04T00:00:00"}
